Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ANVS. [ FAQ on what and how to ask] For non-ANVS questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 101 Lindenwood Drive, Suite 225, Malvern, PA, United States, 19355
Employees: 7
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Founder, Acting CFO, CEO, President & Executive Director
Chief Scientific Officer
Senior Vice President of Regulatory Operations
Head of Quality
Senior Vice President of Statistics
My Watchlist
